Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 9,211,295 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2022-E-2208

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 9,211,295

Documents

Comments

Description

OPEN

Comment Period OpensSep 12, 2022

Comment Period ClosesApr 16, 2024

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Sterne, Kessler, Goldstein & Fox P.L.L.C.

PATENT TERM EXTENSION

Patent Term Extension Application

WINLEVI® (clascoterone),

U.S. Patent No. 9,211,295

OPEN